NRI.TO - Nuvo Pharmaceuticals Inc.

Toronto - Toronto Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 540.08M
Enterprise Value 323.32M
Trailing P/E 12.26
Forward P/E 19.91
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.15
Price/Book (mrq)1.60
Enterprise Value/Revenue 31.25
Enterprise Value/EBITDA 66.27

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017


Profit Margin 18.84%
Operating Margin (ttm)18.71%

Management Effectiveness

Return on Assets (ttm)8.18%
Return on Equity (ttm)15.24%

Income Statement

Revenue (ttm)18.61M
Revenue Per Share (ttm)1.61
Quarterly Revenue Growth (yoy)-46.40%
Gross Profit (ttm)14.27M
Net Income Avi to Common (ttm)3.51M
Diluted EPS (ttm)0.28
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.81M
Total Cash Per Share (mrq)1.54
Total Debt (mrq)8k
Total Debt/Equity (mrq)0.03
Current Ratio (mrq)14.13
Book Value Per Share (mrq)2.17

Cash Flow Statement

Operating Cash Flow (ttm)1.39M
Levered Free Cash Flow (ttm)-1.51M

Trading Information

Stock Price History

Beta -1.00
52-Week Change 3-32.70%
S&P500 52-Week Change 315.48%
52 Week High 35.65
52 Week Low 33.21
50-Day Moving Average 33.45
200-Day Moving Average 33.86

Share Statistics

Avg Vol (3 month) 39.02k
Avg Vol (10 day) 35.08k
Shares Outstanding 511.55M
Float 8.95M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 33.6k
Short Ratio 30.2
Short % of Float 30.00%
Shares Short (prior month) 34k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21354/1000
Last Split Date 3Mar 7, 2016